NASDAQ : VVOS
Vivos Therapeutics, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 0.1138 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.29M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Vivos Therapeutics, Inc. (VVOS) reported revenue of 20.90M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 20.90M | 17.44M | 15.03M | 13.80M | 16.02M | 16.89M |
| Cost of Revenue | 7.96M | 6.90M | 6.01M | 5.53M | 6.00M | 4.28M |
| Gross Profit | 12.94M | 10.54M | 9.02M | 8.27M | 10.02M | 12.60M |
| Selling, General & Admin | 33.70M | 29.13M | 19.61M | 24.95M | 34.18M | 31.34M |
| Research & Development | 200.00K | |||||
| Operating Expenses | 35.49M | 30.44M | 20.19M | 25.57M | 35.05M | 32.08M |
| Operating Income | -22.55M | -19.89M | -11.17M | -17.30M | -25.03M | -19.47M |
| Interest Expense | -2.20M | -14.00K | ||||
| Other Non Operating Income (Expenses) | -1.27M | -1.34M | 35.00K | 3.71M | -101.00K | 108.00K |
| EBT Excluding Unusual Items | -26.03M | -21.23M | -11.14M | -13.58M | -25.13M | -19.38M |
| Asset Writedown | -911.00K | |||||
| Other Unusual Items | 400.00K | 1.29M | ||||
| Pretax Income | -25.63M | -21.23M | -11.14M | -13.58M | -23.84M | -20.29M |
| Earnings From Continuing Operations | -25.63M | -21.23M | -11.14M | -13.58M | -23.84M | -20.29M |
| Minority Interest in Earnings | 171.00K | 60.00K | ||||
| Net Income | -25.46M | -21.17M | -11.14M | -13.58M | -23.84M | -20.29M |
| Net Income to Common | -25.46M | -21.17M | -11.14M | -13.58M | -23.84M | -20.29M |
| Shares Outstanding (Basic) | 13.94M | 10.27M | 5.02M | 1.22M | 920.59K | 849.34K |
| Shares Outstanding (Diluted) | 13.94M | 10.27M | 5.02M | 1.22M | 920.59K | 849.34K |
| EPS (Basic) | -1.83 | -2.06 | -2.22 | -11.14 | -25.90 | -23.89 |
| EPS (Diluted) | -1.83 | -2.06 | -2.22 | -11.14 | -25.90 | -23.89 |
| Free Cash Flow | -19.01M | -17.60M | -13.26M | -12.80M | -20.51M | -18.13M |
| Free Cash Flow Per Share | -1.36 | -1.71 | -2.64 | -10.50 | -22.28 | -21.35 |
| Gross Margin | 61.90% | 60.44% | 60.00% | 59.93% | 62.52% | 74.65% |
| Operating Margin | -107.90% | -114.05% | -74.32% | -125.32% | -156.21% | -115.31% |
| Profit Margin | -121.79% | -121.37% | -74.09% | -98.42% | -148.81% | -120.15% |
| Free Cash Flow Margin | -90.96% | -100.92% | -88.21% | -92.74% | -128.00% | -107.38% |
| EBITDA | -20.76M | -18.59M | -10.59M | -16.68M | -24.36M | -18.74M |
| EBITDA Margin | -99.33% | -106.55% | -70.45% | -120.82% | -152.03% | -110.97% |
| D&A For EBITDA | 1.79M | 1.31M | 581.00K | 621.00K | 669.00K | 733.00K |
| EBIT | -22.55M | -19.89M | -11.17M | -17.30M | -25.03M | -19.47M |
| EBIT Margin | -107.90% | -114.05% | -74.32% | -125.32% | -156.21% | -115.31% |
| Revenue as Reported | 20.90M | 17.44M | 15.03M | 13.80M | 16.02M | 16.89M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.77M | 2.03M | 6.26M | 1.64M | 3.52M | 24.03M |
| Cash & Short-Term Investments | 1.77M | 2.03M | 6.26M | 1.64M | 3.52M | 24.03M |
| Accounts Receivable | 1.44M | 1.58M | 430.00K | 202.00K | 457.00K | 1.72M |
| Receivables | 1.44M | 1.58M | 430.00K | 202.00K | 457.00K | 1.72M |
| Prepaid Expenses | 1.00M | 774.00K | 783.00K | 616.00K | 1.45M | 1.57M |
| Total Current Assets | 4.21M | 4.38M | 7.47M | 2.46M | 5.42M | 27.32M |
| Property, Plant & Equipment | 7.45M | 7.92M | 4.34M | 4.70M | 4.78M | 2.83M |
| Goodwill | 8.57M | 8.57M | 2.84M | 2.84M | 2.84M | 2.84M |
| Other Intangible Assets | 3.64M | 4.04M | 409.00K | 420.00K | 302.00K | 341.00K |
| Other Long-Term Assets | 272.00K | 228.00K | 216.00K | 307.00K | 374.00K | 356.00K |
| Total Assets | 24.14M | 25.15M | 15.28M | 10.73M | 13.72M | 33.69M |
| Accounts Payable | 2.95M | 1.68M | 1.10M | 2.15M | 1.41M | 920.00K |
| Accrued Expenses | 7.04M | 5.99M | 2.23M | 2.33M | 1.91M | 2.85M |
| Current Portion of Long-Term Debt | 7.77M | 8.35M | 1.26M | |||
| Current Portion of Leases | 846.00K | 727.00K | 477.00K | 474.00K | 419.00K | |
| Current Unearned Revenue | 583.00K | 479.00K | 896.00K | 2.14M | 2.93M | 2.40M |
| Other Current Liabilities | 1.20M | 850.00K | 273.00K | 198.00K | 145.00K | 72.00K |
| Total Current Liabilities | 20.39M | 18.08M | 4.98M | 7.29M | 6.81M | 7.51M |
| Long-Term Debt | 366.00K | 469.00K | ||||
| Long-Term Leases | 3.52M | 3.95M | 1.03M | 1.52M | 1.99M | |
| Long-Term Unearned Revenue | 97.00K | 289.00K | 112.00K | |||
| Other Long-Term Liabilities | 3.85M | 4.20M | 1.22M | 1.22M | 641.00K | |
| Total Liabilities | 28.13M | 26.70M | 7.33M | 10.32M | 8.92M | 8.15M |
| Common Stock | 1.00K | 1.00K | 2.00K | |||
| Additional Paid-In Capital | 133.60M | 123.87M | 112.14M | 93.46M | 84.27M | 81.16M |
| Retained Earnings | -138.52M | -125.36M | -104.19M | -93.05M | -79.47M | -55.62M |
| Total Common Equity | -4.92M | -1.49M | 7.95M | 411.00K | 4.80M | 25.54M |
| Minority Interest | -171.00K | -60.00K | ||||
| Shareholders' Equity | -3.99M | -1.55M | 7.95M | 411.00K | 4.80M | 25.54M |
| Total Liabilities & Equity | 24.14M | 25.15M | 15.28M | 10.73M | 13.72M | 33.69M |
| Total Debt | 12.51M | 13.50M | 1.51M | 2.00M | 2.41M | 1.26M |
| Net Cash (Debt) | -10.73M | -11.47M | 4.75M | -352.00K | 1.11M | 22.77M |
| Net Cash Per Share | -0.77 | -1.12 | 0.95 | -0.29 | 1.20 | 26.80 |
| Filing Date Shares Outstanding | 20.12M | 13.49M | 5.89M | 2.73M | 1.19M | 920.49K |
| Total Common Shares Outstanding | 14.53M | 9.29M | 5.89M | 1.83M | 920.49K | 920.49K |
| Working Capital | -16.18M | -13.69M | 2.50M | -4.83M | -1.39M | 19.82M |
| Book Value Per Share | -0.34 | -0.16 | 1.35 | 0.22 | 5.22 | 27.75 |
| Tangible Book Value | -17.13M | -14.11M | 4.70M | -2.85M | 1.66M | 22.36M |
| Tangible Book Value Per Share | -1.18 | -1.52 | 0.80 | -1.56 | 1.80 | 24.29 |
| Machinery | 3.63M | 3.50M | 1.75M | 1.73M | 1.41M | 1.47M |
| Construction In Progress | 1.86M | 1.44M | 948.00K | 212.00K | ||
| Leasehold Improvements | 3.49M | 3.20M | 2.48M | 2.48M | 2.48M | 2.39M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -25.46M | -21.17M | -11.14M | -13.58M | -23.84M | -20.29M |
| Depreciation & Amortization | 1.79M | 1.31M | 581.00K | 621.00K | 669.00K | 733.00K |
| Loss (Gain) From Sale of Assets | 36.00K | |||||
| Stock-Based Compensation | 889.00K | 661.00K | 793.00K | 1.84M | 3.11M | 2.91M |
| Other Operating Activities | -271.00K | -60.00K | 11.00K | -3.69M | -1.26M | 882.00K |
| Change in Accounts Receivable | 195.00K | -217.00K | -228.00K | 255.00K | 746.00K | 228.00K |
| Change in Accounts Payable | 1.18M | 524.00K | -1.05M | 734.00K | 491.00K | 139.00K |
| Change in Unearned Revenue | 98.00K | -514.00K | -1.43M | -611.00K | 638.00K | -539.00K |
| Change in Other Net Operating Assets | 4.44M | 4.20M | -230.00K | 2.49M | -164.00K | 200.00K |
| Operating Cash Flow | -17.13M | -15.26M | -12.69M | -11.95M | -19.59M | -15.73M |
| Capital Expenditures | -1.88M | -2.34M | -568.00K | -853.00K | -924.00K | -2.40M |
| Cash Acquisitions | -50.00K | -5.18M | -225.00K | |||
| Other Investing Activities | 13.00K | |||||
| Investing Cash Flow | -1.93M | -7.53M | -568.00K | -853.00K | -924.00K | -2.61M |
| Long-Term Debt Issued | 10.67M | |||||
| Long-Term Debt Repaid | -28.00K | -25.00K | ||||
| Net Debt Issued (Repaid) | 2.78M | 10.64M | -25.00K | |||
| Issuance of Common Stock | 13.23M | 8.75M | 19.24M | 12.00M | 27.93M | |
| Other Financing Activities | -678.00K | -837.00K | -1.36M | -1.08M | -2.24M | |
| Financing Cash Flow | 16.43M | 18.56M | 17.88M | 10.92M | 24.17M | |
| Net Cash Flow | -2.63M | -4.23M | 4.62M | -1.88M | -20.51M | 5.82M |
| Free Cash Flow | -19.01M | -17.60M | -13.26M | -12.80M | -20.51M | -18.13M |
| Free Cash Flow Margin | -90.96% | -100.92% | -88.21% | -92.74% | -128.00% | -107.38% |
| Free Cash Flow Per Share | -1.36 | -1.71 | -2.64 | -10.50 | -22.28 | -21.35 |
| Levered Free Cash Flow | -8.53M | -9.41M | -8.84M | -8.61M | -11.25M | -11.27M |
| Unlevered Free Cash Flow | -7.16M | -9.41M | -8.84M | -8.61M | -11.25M | -11.26M |
| Cash Interest Paid | 568.00K | 9.00K | 18.00K | |||
| Change in Working Capital | 5.92M | 4.00M | -2.94M | 2.86M | 1.71M | 28.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.29M | 18.25M | 25.27M | 14.89M | 9.25M | 51.78M |
| Enterprise Value | 13.02M | 27.66M | 20.60M | 16.01M | 5.38M | 24.51M |
| Last Close Price | 0.11 | 2.03 | 4.29 | 12.44 | 10.05 | 56.25 |
| PS Ratio | 0.11 | 1.05 | 1.68 | 1.08 | 0.58 | 3.07 |
| PB Ratio | -11.77 | 3.18 | 36.24 | 1.93 | 2.03 | |
| P/TBV Ratio | 5.37 | 5.59 | 2.32 | |||
| EV/Sales Ratio | 0.62 | 1.59 | 1.37 | 1.16 | 0.34 | 1.45 |
| Debt / Equity Ratio | -3.14 | -8.71 | 0.19 | 4.85 | 0.50 | 0.05 |
| Net Debt / Equity Ratio | -2.69 | -7.40 | -0.60 | 0.86 | -0.23 | -0.89 |
| Net Debt / EBITDA Ratio | -0.52 | -0.62 | 0.45 | -0.02 | 0.04 | 1.22 |
| Net Debt / FCF Ratio | -0.56 | -0.65 | 0.36 | -0.03 | 0.05 | 1.26 |
| Asset Turnover | 0.83 | 0.86 | 1.16 | 1.13 | 0.68 | 0.57 |
| Quick Ratio | 0.16 | 0.20 | 1.34 | 0.25 | 0.58 | 3.43 |
| Current Ratio | 0.21 | 0.24 | 1.50 | 0.34 | 0.80 | 3.64 |
| Return on Equity (ROE) | -8,585.26% | -663.02% | -266.25% | -521.22% | -157.19% | -92.31% |
| Return on Assets (ROA) | -56.19% | -61.50% | -53.68% | -88.42% | -66.00% | -41.24% |
| Return on Capital Employed (ROCE) | -600.60% | -281.10% | -108.40% | -502.60% | -362.40% | -74.40% |
| Earnings Yield | -1,605.15% | -116.03% | -44.07% | -91.20% | -257.76% | -39.18% |
| FCF Yield | -830.47% | -96.48% | -52.48% | -85.93% | -221.72% | -35.02% |
| Buyback Yield / Dilution | -72.97% | -104.66% | -311.68% | -32.46% | -8.39% | -65.00% |